Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Systematic and combined endosonographic staging of lung cancer (SCORE study).

Crombag LMM, Dooms C, Stigt JA, Tournoy KG, Schuurbiers OCJ, Ninaber MK, Buikhuisen WA, Hashemi SMS, Bonta PI, Korevaar DA, Annema JT.

Eur Respir J. 2019 Feb 7;53(2). pii: 1800800. doi: 10.1183/13993003.00800-2018. Print 2019 Feb.

PMID:
30578389
2.

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma.

Quispel-Janssen J, van der Noort V, de Vries JF, Zimmerman M, Lalezari F, Thunnissen E, Monkhorst K, Schouten R, Schunselaar L, Disselhorst M, Klomp H, Hartemink K, Burgers S, Buikhuisen W, Baas P.

J Thorac Oncol. 2018 Oct;13(10):1569-1576. doi: 10.1016/j.jtho.2018.05.038. Epub 2018 Jun 14.

3.

Rapid on-site evaluation during endoscopic ultrasound-guided fine-needle aspiration of lymph nodes does not increase diagnostic yield: A randomized, multicenter trial.

Kappelle WFW, Van Leerdam ME, Schwartz MP, Bülbül M, Buikhuisen WA, Brink MA, Sie-Go DMDS, Pullens HJM, Nikolakopoulos S, Van Diest PJ, Leenders M, Moons LMG, Bogte A, Siersema PD, Vleggaar FP.

Am J Gastroenterol. 2018 May;113(5):677-685. doi: 10.1038/s41395-018-0025-8. Epub 2018 Apr 23.

PMID:
29681624
4.

The utility of blood neuroendocrine gene transcript measurement in the diagnosis of bronchopulmonary neuroendocrine tumours and as a tool to evaluate surgical resection and disease progression.

Filosso PL, Kidd M, Roffinella M, Lewczuk A, Chung KM, Kolasinska-Cwikla A, Cwikla J, Lowczak A, Doboszynska A, Malczewska A, Catalano M, Zunino V, Boita M, Arvat E, Cristofori R, Guerrera F, Oliaro A, Tesselaar M, Buikhuisen W, Kos-Kudla B, Papotti M, Bodei L, Drozdov I, Modlin I.

Eur J Cardiothorac Surg. 2018 Mar 1;53(3):631-639. doi: 10.1093/ejcts/ezx386.

PMID:
29145657
5.

Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial.

Ferolla P, Brizzi MP, Meyer T, Mansoor W, Mazieres J, Do Cao C, Léna H, Berruti A, Damiano V, Buikhuisen W, Grønbæk H, Lombard-Bohas C, Grohé C, Minotti V, Tiseo M, De Castro J, Reed N, Gislimberti G, Singh N, Stankovic M, Öberg K, Baudin E.

Lancet Oncol. 2017 Dec;18(12):1652-1664. doi: 10.1016/S1470-2045(17)30681-2. Epub 2017 Oct 23.

PMID:
29074099
6.

Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.

Semenova EA, Kwon MC, Monkhorst K, Song JY, Bhaskaran R, Krijgsman O, Kuilman T, Peters D, Buikhuisen WA, Smit EF, Pritchard C, Cozijnsen M, van der Vliet J, Zevenhoven J, Lambooij JP, Proost N, van Montfort E, Velds A, Huijbers IJ, Berns A.

Cell Rep. 2016 Jul 19;16(3):631-43. doi: 10.1016/j.celrep.2016.06.020. Epub 2016 Jun 30.

7.

A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes.

Buikhuisen WA, Scharpfenecker M, Griffioen AW, Korse CM, van Tinteren H, Baas P.

J Thorac Oncol. 2016 May;11(5):758-768. doi: 10.1016/j.jtho.2016.01.014. Epub 2016 Feb 2.

8.

Neuroendocrine Cancer of the Lung: A Diagnostic Puzzle.

Derks JL, Speel EJ, Thunnissen E, van Suylen RJ, Buikhuisen WA, van Velthuysen ML, Dingemans AM.

J Thorac Oncol. 2016 Mar;11(3):e35-8. doi: 10.1016/j.jtho.2015.10.013. Epub 2015 Dec 24.

9.

Clinical features of large cell neuroendocrine carcinoma: a population-based overview.

Derks JL, Hendriks LE, Buikhuisen WA, Groen HJ, Thunnissen E, van Suylen RJ, Houben R, Damhuis RA, Speel EJ, Dingemans AM.

Eur Respir J. 2016 Feb;47(2):615-24. doi: 10.1183/13993003.00618-2015. Epub 2015 Nov 5.

10.

Second line therapy in malignant pleural mesothelioma: A systematic review.

Buikhuisen WA, Hiddinga BI, Baas P, van Meerbeeck JP.

Lung Cancer. 2015 Sep;89(3):223-31. doi: 10.1016/j.lungcan.2015.06.018. Epub 2015 Jun 23. Review.

PMID:
26162564
11.

Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.

Krug LM, Kindler HL, Calvert H, Manegold C, Tsao AS, Fennell D, Öhman R, Plummer R, Eberhardt WE, Fukuoka K, Gaafar RM, Lafitte JJ, Hillerdal G, Chu Q, Buikhuisen WA, Lubiniecki GM, Sun X, Smith M, Baas P.

Lancet Oncol. 2015 Apr;16(4):447-56. doi: 10.1016/S1470-2045(15)70056-2. Epub 2015 Mar 20. Erratum in: Lancet Oncol. 2015 May;16(5):e199.

PMID:
25800891
12.

Differential motion between mediastinal lymph nodes and primary tumor in radically irradiated lung cancer patients.

Schaake EE, Rossi MM, Buikhuisen WA, Burgers JA, Smit AA, Belderbos JS, Sonke JJ.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):959-66. doi: 10.1016/j.ijrobp.2014.07.038. Epub 2014 Oct 18.

PMID:
25585787
13.

Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study.

Buikhuisen WA, Burgers JA, Vincent AD, Korse CM, van Klaveren RJ, Schramel FM, Pavlakis N, Nowak AK, Custers FL, Schouwink JH, Gans SJ, Groen HJ, Strankinga WF, Baas P.

Lancet Oncol. 2013 May;14(6):543-51. doi: 10.1016/S1470-2045(13)70125-6. Epub 2013 Apr 12.

PMID:
23583604
14.

Mediastinal lymph node position variability in non-small cell lung cancer patients treated with radical irradiation.

Schaake EE, Belderbos JS, Buikhuisen WA, Rossi MM, Burgers JA, Sonke JJ.

Radiother Oncol. 2012 Nov;105(2):150-4. doi: 10.1016/j.radonc.2012.09.007. Epub 2012 Oct 22.

PMID:
23089305
15.

Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?

Buikhuisen WA, Burgers JA, Vincent AD, Schellens JH, Beijnen JH, Smit EF, Joerger M.

J Clin Oncol. 2010 Sep 20;28(27):e482-3; author reply e484. doi: 10.1200/JCO.2010.29.1559. Epub 2010 Jul 6. No abstract available.

PMID:
20606096
16.

[Recurrent, itching and creeping skin lesions in (former) travellers to the tropics: strongyloidiasis].

Buikhuisen WA, Wetsteyn JC, van Gool T, Kager PA.

Ned Tijdschr Geneeskd. 2002 Mar 9;146(10):477-81. Dutch.

PMID:
11913114
17.

[Malaise after a trip to Africa: amoebic liver abscess].

Buikhuisen WA, Wetsteyn JC, van Gool T, Kager PA.

Ned Tijdschr Geneeskd. 2002 Mar 2;146(9):423-7. Dutch.

PMID:
11901944
18.

High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes.

Haber BA, Chin S, Chuang E, Buikhuisen W, Naji A, Taub R.

J Clin Invest. 1995 Feb;95(2):832-41.

19.

Protein tyrosine kinase activity and its substrates in rat intestinal microvillus membranes.

Thompson JF, Buikhuisen WA.

Gastroenterology. 1990 Aug;99(2):370-9.

PMID:
1973132
20.

Crime and recovery time: Mednick revisited.

Buikhuisen W, Eurelings-Bontekoe EH, Høst KB.

Int J Law Psychiatry. 1989;12(1):29-40. No abstract available.

PMID:
2793294
21.

Characteristics of criminals: the privileged offender.

Buikhuisen W, Bontekoe EH, vd Plas-Korenhoff C, van Buuren S.

Int J Law Psychiatry. 1984;7(3-4):301-13. No abstract available.

PMID:
6537416
22.

Aggressive behavior and cognitive disorders.

Buikhuisen W.

Int J Law Psychiatry. 1982;5(2):205-17. No abstract available.

PMID:
7118343
23.

Traffic perception under the influence of alcohol.

Buikhuisen W, Jongman RW.

Q J Stud Alcohol. 1972 Sep;33(3):800-6. No abstract available.

PMID:
5076884
24.

The development of drug-taking among secondary school children in the Netherlands.

Buikhuisen W, Timmerman H.

Bull Narc. 1972 Jul-Sep;24(3):7-16. No abstract available.

PMID:
4486203

Supplemental Content

Loading ...
Support Center